Filters

Anti-CD154 Antibody (Biotin)

Anti-CD154 Antibody (Biotin) size: 100 μg 369

Supplier ABBEX
Price 369
Size 100 μg
CategoryPrimary Antibodies
TargetCD154 Antibody
ImmunogenSee techfile
ClonalityMonoclonal
Raised inHamster
Reactivity Mouse, Rat, Human
FormBiotin
PurificationAffinity purified
ApplicationsWB (for other see techfile or inquire)
Stock availabilityShipped within 5-12 working days
Storage conditions Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C
WarningsThis product is for research use only
Properties Avidin and Streptavidin bind to the small biotin and are couple to HRP or AP for ELISA, Biotin conjugates can be detected by horseradish peroxidase, To break the streptavidin Biotin bond we suggest to use a 6 molar guanidine HCl solution with acidity of pH 1, alkaline phosphatase substrates or anti biotin conjugated antibodies, 6, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by abbex they should be stored frozen at - 24°
ConjugationBiotinylated
Gene targetCD154
Short nameAnti-CD154 Antibody ( )
Technique antibodies against human proteins, antibodies for, Antibody
LabelBiotin
Alternative nameantibody to-CD154 (Antibody to) (biotinilated)
Alternative techniqueantibodies
Identity 11935
Gene CD40LG
Long gene name CD40 ligand
Synonyms gene HIGM1 IMD3 TNFSF5
Synonyms gene name member 5 (hyper-IgM syndrome) , tumor necrosis factor (ligand) superfamily
Synonyms CD40L TRAP gp39 hCD40L CD154
Synonyms name CD40 antigen ligand tumor necrosis factor (ligand) superfamily member 5 T-B cell-activating molecule TNF-related activation protein hyper-IgM syndrome
Locus Xq26, 3
Discovery year 1989-06-30
GenBank acession X67878
Entrez gene record 959
Pubmed identfication 1427881 7678782
RefSeq identity NM_000074
Classification Endogenous ligands Tumor necrosis factor superfamily CD molecules
Havana BLAST/BLAT OTTHUMG00000022512
Locus Specific Databases CD40Lbase: Mutation registry for X-linked Hyper-IgM syndrome Mental Retardation database LRG_141

Subscribe to our Newsletter